Compute Health Acquisition Corp

Compute Health Acquisition Corp

CPUH-WT
Compute Health Acquisition CorpUS flagNew York Stock Exchange
0.53
USD
-0.03
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Financial Services
Industry
Shell Companies
Address
Business
Compute Health Acquisition Corp Compute Health Acquisition Corp (CPUH-WT) operates as a blank check company, or special purpose acquisition company, focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting healthcare companies leveraging computational power such as those in medical devices, imaging, and robotics; its core offerings include public units, redeemable Class A common stock, and public warrants exercisable into Class A shares at a specified price. Incorporated in 2020 as a Delaware corporation and headquartered at 1105 North Market Street, Suite 1300, Wilmington, Delaware, the company raised $750 million in its February 2021 initial public offering underwritten by Goldman Sachs. In July 2023, Compute Health Acquisition Corp stockholders approved its business combination with Allurion Technologies, Inc., a weight loss platform provider featuring the swallowable Allurion Gastric Balloon, Virtual Care Suite, and connected devices; the merger closed shortly thereafter with Compute Health merging into Allurion, resulting in Allurion Technologies Holdings, Inc. trading on the NYSE under ALUR while CPUH-WT warrants were assumed and converted into Allurion public warrants, reflecting the company's completed strategic shift to support obesity treatment innovation through computational healthcare advancements.